Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women's health and wellness company. It is focused on the commercialization of a revolutionary, non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The Viveve System incorporates clinically-proven, cryogen-cooled, monopolar radiofrequency (CMRF) energy to uniformly deliver deep- penetrating volumetric heat while gently cooling surface tissue to treat the condition of vaginal laxity.
Company Growth (employees)
Type
Public
HQ
Sunnyvale, US
Founded
2005
Size (employees)
42 (est)
Website
viveve.com
Viveve was founded in 2005 and is headquartered in Sunnyvale, US

Viveve Office Locations

Viveve has an office in Sunnyvale
Sunnyvale, US (HQ)
150 Commercial St

Viveve Data and Metrics

Viveve Financial Metrics

Viveve's revenue was reported to be $3 m in Q1, 2017
USD

Revenue (Q1, 2017)

3 m

Gross profit (Q1, 2017)

1.4 m

Gross profit margin (Q1, 2017), %

47%

EBIT (Q1, 2017)

(6.4 m)

Market capitalization (18-Aug-2017)

103.3 m

Cash (31-Mar-2017)

31.4 m
Viveve's current market capitalization is $103.3 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.3 m90 k1.4 m7.1 m

Revenue growth, %

(93%)1508%394%

Cost of goods sold

531 k50 k985 k4.6 m

Gross profit

743 k40 k462 k2.5 m

Gross profit Margin, %

58%44%32%35%

R&D expense

8.4 m

General and administrative expense

12.9 m

Operating expense total

5.4 m5.7 m12.5 m21.2 m

EBIT

(4.7 m)(5.7 m)(12 m)(18.7 m)

EBIT margin, %

(369%)(6291%)(829%)(262%)

Interest expense

337 k567 k415 k1.4 m

Net Income

3.5 m(6.2 m)(12.4 m)(20.1 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

73 k17.2 k38 k73 k584 k1.3 m1.6 m1.8 m3 m

Cost of goods sold

24 k14.7 k50 k53 k417 k936 k1 m1.2 m1.6 m

Gross profit

49 k2.5 k(12 k)20 k167 k348 k534 k691 k1.4 m

Gross profit Margin, %

67%14%(32%)27%29%27%34%37%47%

R&D expense

428 k572.1 k845 k1.1 m1.5 m1.8 m2.5 m2.1 m2.4 m

General and administrative expense

812 k1.8 m1.6 m1.8 m1.8 m2.5 m2.6 m3.3 m5.5 m

Operating expense total

1.2 m2.4 m2.4 m2.9 m3.3 m4.3 m5.1 m5.3 m7.8 m

EBIT

(1.2 m)(2.4 m)(2.4 m)(2.9 m)(3.1 m)(4 m)(4.5 m)(4.6 m)(6.4 m)

EBIT margin, %

(1632%)(13735%)(6405%)(3955%)(532%)(311%)(292%)(251%)(211%)

Interest expense

(71 k)(152.3 k)(83 k)(105 k)(114 k)(108 k)(765 k)(221 k)(263 k)

Interest income

2

Net Income

2.3 m(2.5 m)(2.5 m)(3 m)(3.2 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

769 k895 k7.4 m8.1 m

Accounts Receivable

6 k593 k2.1 m

Inventories

117 k923 k1.6 m2.7 m

Current Assets

1.5 m2 m11.1 m13.9 m

PP&E

187 k239 k483 k

Total Assets

1.6 m2.3 m11.5 m14.5 m

Accounts Payable

425 k416 k1.4 m3.1 m

Current Liabilities

983 k3.1 m7.1 m

Total Liabilities

15 m

Additional Paid-in Capital

48 k22.4 m68.2 m

Retained Earnings

(103.6 m)(36.1 m)(48.5 m)(68.6 m)

Total Equity

3.9 m(405 k)

Financial Leverage

2.9 x-35.9 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

87 k2 m221 k8.4 m6.1 m5 m19.9 m14 m31.4 m

Accounts Receivable

3.8 k35 k6 k239 k791 k589 k1.8 m4 m

Inventories

101 k136.9 k167 k337 k645 k926 k845 k1.4 m2.4 m

Current Assets

704 k2.3 m1.3 m10.4 m8.6 m8.3 m22.6 m18.5 m39 m

PP&E

191.7 k170 k172 k198 k254 k356 k445 k791 k

Total Assets

721 k3.1 m1.6 m10.8 m8.9 m8.7 m23.1 m19.1 m40 m

Accounts Payable

775 k566.1 k612 k612 k1.1 m1.6 m1.9 m2.5 m3.4 m

Current Liabilities

1.8 m2.4 m4.7 m3.9 m5.3 m8.3 m

Common Stock

35.1 m

Additional Paid-in Capital

145 k67.5 m67.9 m100.1 m

Retained Earnings

(103.7 m)(34.3 m)(38.6 m)(41.6 m)(44.8 m)(52.6 m)(57.9 m)(62.8 m)(75.3 m)

Total Equity

5.1 m2 m436 k9.6 m5.1 m24.8 m

Financial Leverage

2.1 x4.5 x19.9 x2.4 x3.8 x1.6 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

3.5 m(6.2 m)(12.4 m)(20.1 m)

Depreciation and Amortization

53 k56 k77 k111 k

Accounts Receivable

(80 k)(6 k)(587 k)(1.5 m)

Inventories

42 k(41 k)(879 k)(1.2 m)

Accounts Payable

48 k(551 k)1 m1.7 m

Cash From Operating Activities

511 k(6 m)(12.2 m)(18.1 m)

Purchases of PP&E

(117 k)(109 k)(256 k)

Cash From Investing Activities

(117 k)(109 k)(256 k)

Cash From Financing Activities

5.3 m6.6 m18.8 m19.1 m

Interest Paid

107 k149 k196 k803 k

Income Taxes Paid

1 k1 k1 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

2.3 m(2.5 m)(2.5 m)(3 m)(3.2 m)

Accounts Receivable

3.8 k35 k6 k239 k791 k589 k1.8 m4 m

Inventories

101 k136.9 k167 k337 k645 k926 k845 k1.4 m2.4 m

Accounts Payable

775 k566.1 k612 k612 k1.1 m1.6 m1.9 m2.5 m3.4 m
USDY, 2017

Revenue/Employee

72.4 k

Financial Leverage

1.6 x

Viveve Market Value History

Traffic Overview of Viveve

Viveve Online and Social Media Presence

Viveve Company Life and Culture

You may also be interested in